| ID |
PMID |
Sequence |
Chirality |
Peptide name |
Origin |
Family |
Nature |
Sub-cellular localization |
N terminal modification |
C terminal modification |
Uptake efficiency |
Uptake mechanism |
Cancer cell lines |
Patent number |
|
| 1001 | 9188504 | GRKKRRQRRRPPQ | L | Tat (48-60) | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus, nucelolus | Labelled with Cys-acetamidomethyl | Labelled with fluorescein maleimide | High | Non-endocytic pathway | HeLa | US 20040132970 |
|
| 1002 | 9188504 | LGISYGRKKRRQRRRPPQ | L | Tat (43-60) | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus, nucelolus | Labelled with Cys-acetamidomethyl | Labelled with fluorescein maleimide | High | Non-endocytic pathway | HeLa | US 6740524 |
|
| 1003 | 9188504 | FITKALGISYGRKKRRQRRRPPQ | L | Tat (37-60) | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus, nucelolus | Labelled with Cys-acetamidomethyl | Labelled with fluorescein maleimide | High | Non-endocytic pathway | HeLa | Unknown |
|
| 1004 | 9188504 | FITKALGISYGRKKRR | L | Tat (37-53) | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus, nucelolus | Labelled with Cys-acetamidomethyl | Labelled with fluorescein maleimide | Low | Non-endocytic pathway | HeLa | Unknown |
|
| 1005 | Unknown | GRKKRRQRRR | L | Tat (48-57) | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus, nucelolus | Labelled with Cys-acetamidomethyl | Labelled with fluorescein maleimide | High | Non-endocytic pathway | HeLa | US 20100216716 |
|
| 1006 | 11087855 | RKKRRQRRR | L | Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | High | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1007 | 11087855 | RKKRRQRR | L | Tat (49-56) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Medium (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1008 | 11087855 | RKKRRQR | L | Tat (49-55) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1009 | 11087855 | KKRRQRRR | L | Tat (50-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1010 | 11087855 | KRRQRRR | L | Tat (51-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1011 | 11087855 | rkkrrqrrr | D | D-Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | High (greater than Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1012 | 11087855 | RRRQRRKKR | L | Retro - Tat (57-49) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | High (greater than Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1013 | 11087855 | rrrqrrkkr | D | D-Tat (57-49) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | High (greater than Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1014 | 11087855 | AKKRRQRRR | L | Ala49 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1015 | 11087855 | RAKRRQRRR | L | Ala50 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1016 | 11087855 | RKARRQRRR | L | Ala51 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1017 | 11087855 | RKKARQRRR | L | Ala52 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1018 | 11087855 | RKKRAQRRR | L | Ala53 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1019 | 11087855 | RKKRRARRR | L | Ala54 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Medium (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1020 | 11087855 | RKKRRQARR | L | Ala55 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1021 | 11087855 | RKKRRQRAR | L | Ala56 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1022 | 11087855 | RKKRRQRRA | L | Ala57 substitution mutant of Tat (49-57) | HIV-1 | Protein derived | Cationic | Probably cytoplasm and nucleus, nucleolus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1023 | Unknown | GRKKRRQRRPPQC | L | Arg deletion mutant of Tat (48-60) | HIV-1 | Protein derived | Cationic | Nucleus and nucleolus | Free | Labelled with fluorescein | Medium (50 % relative to Tat (48-60)) | Probably non-endocytic pathway | HeLa | Unknown |
|
| 1024 | Unknown | GRKKRRQRPPQC | L | Arg deletion mutant of Tat (48-60) | HIV-1 | Protein derived | Cationic | Nucleus and nucleolus | Free | Labelled with fluorescein | Low (25 % relative to Tat (48-60)) | Probably non-endocytic pathway | HeLa | Unknown |
|
| 1025 | Unknown | GRKKRRQPPQC | L | Arg deletion mutant of Tat (48-60) | HIV-1 | Protein derived | Cationic | Nucleus and nucleolus | Free | Labelled with fluorescein | Low (10 % relative to Tat (48-60)) | Probably non-endocytic pathway | HeLa | Unknown |
|
| 1026 | Unknown | GRKKRRQRRRC | L | Pro deletion mutant of Tat (48-60) | HIV-1 | Protein derived | Cationic | Nucleus and nucleolus | Free | Labelled with fluorescein | Medium (80 % relative to Tat (48-60)) | Probably non-endocytic pathway | HeLa | Unknown |
|
| 1027 | Unknown | GRKKRRQRARPPQC | L | Ala substitution mutant of Tat (48-60) | HIV-1 | Protein derived | Cationic | Nucleus and nucleolus | Free | Labelled with fluorescein | Medium (35 % relative to Tat (48-60)) | Probably non-endocytic pathway | HeLa | Unknown |
|
| 1028 | Unknown | GRKKRRQARAPPQC | L | Ala substitution mutant of Tat (48-60) | HIV-1 | Protein derived | Cationic | Nucleus and nucleolus | Free | Labelled with fluorescein | Low (15 % relative to Tat (48-60)) | Probably non-endocytic pathway | HeLa | Unknown |
|
| 1029 | 11084031 | TRQARRNRRRRWRERQR | L | Rev (34-50) | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Cystein amide labelled with fluorescein | High (comparable to Tat (48-60) | Non-endocytic pathway | RAW 264.7 | US 20060223752 |
|
| 1030 | 11084031 | RRRR | L | R4 | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Free | C-terminal Cystein amide labelled with fluorescein | Very low | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1031 | 11087855 | RRRRR | L | R5 | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1032 | 11087855 | RRRRRR | L | R6 | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | Medium (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1033 | 11087855 | RRRRRRR | L | R7 | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1034 | 11087855 | RRRRRRRR | L | R8 | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1035 | 11087855 | RRRRRRRRR | L | R9 | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1036 | 11084031 | RRRRRRRRRRR | L | R10 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | High, less than R8 | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1037 | 11084031 | RRRRRRRRRRRR | L | R12 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Low | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1038 | 11084031 | RRRRRRRRRRRRRRRR | L | R16 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Low | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1039 | 11087855 | rrrrr | D | D-R5 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | Low (relative to Tat (49-57)) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1040 | 11087855 | rrrrrr | D | D-R6 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (comparable to Tat (49-57) and higher than R6 | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1041 | 11087855 | rrrrrrr | D | D-R7 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (relative to both Tat (49-57) and R7) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1042 | 11087855 | rrrrrrrr | D | D-R8 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (relative to both Tat (49-57) and R7) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1043 | 11087855 | rrrrrrrrr | D | D-R9 | Positively charged sequence | Synthetic | Cationic | Probably cytoplasm and nucleus | Labelled with fluorescein with aminohexanoic space | Free | High (relative to both Tat (49-57) and R7) | Probably non-endocytic pathway | Jurkat | US 6593292 |
|
| 1061 | 10323198 | KLALKLALKALKAALKLA | L | I | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | High (pmol internalized peptide/mg protein = 228) | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1062 | 10323198 | KLALKLALKAWKAALKLA | L | KLA1 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Medium relative to I (pmol internalized peptide/mg | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1063 | 10323198 | KLALKAALKAWKAAAKLA | L | KLA2 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1064 | 10323198 | KLALKAAAKAWKAAAKAA | L | KLA3 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1065 | 10323198 | KITLKLAIKAWKLALKAA | L | KLA11 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1066 | 10323198 | KIAAKSIAKIWKSILKIA | L | KLA5 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1067 | 10323198 | KALAKALAKLWKALAKAA | L | KLA12 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Medium relative to I (pmol internalized peptide/mg | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1068 | 10323198 | KLALKLALKWAKLALKAA | L | KLA13 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1069 | 10323198 | KLLAKAAKKWLLLALKAA | L | KLA14 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1070 | 10323198 | KLLAKAALKWLLKALKAA | L | KLA9 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | Low relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1071 | 10323198 | KALKKLLAKWLAAAKALL | L | KLA10 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | High and comparable to I (pmol internalized peptid | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1072 | 10323198 | KLAAALLKKWKKLAAALL | L | KLA15 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | High and comparable to I (pmol internalized pepti | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1073 | 10323198 | KALAALLKKWAKLLAALK | L | KLA8 | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Free | Amidation | High and comparable to I (pmol internalized pepti | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1074 | 10323198 | KALAALLKKLAKLLAALK | L | II | Designed Model peptide | Synthetic | Amphipathic | Probably cytoplasm and nucleus | Labelled with fluorescein | Amidation | High relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1075 | 10323198 | KLALKLALKALKAALK | L | III | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Comparable to I (pmol internalized peptide/mg prot | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1076 | 10323198 | KLALKALKAALKLA | L | IV | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1077 | 10323198 | KLALKLALKALKAA | L | V | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1078 | 10323198 | KLGLKLGLKGLKGGLKLG | L | VI | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1079 | 10323198 | KLALKLALKALQAALQLA | L | VII | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1080 | 10323198 | KLALQLALQALQAALQLA | L | VIII | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | High relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1081 | 10323198 | QLALQLALQALQAALQLA | L | IX | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | High relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1082 | 10323198 | ELALELALEALEAALELA | L | X | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1083 | 10323198 | LKTLATALTKLAKTLTTL | L | XI | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | High relative to I (pmol internalized peptide/mg p | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1084 | 10323198 | LLKTTALLKTTALLKTTA | L | XII | Designed Model peptide | Synthetic | Non-amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Unknown | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1085 | 10323198 | LKTLTETLKELTKTLTEL | L | XIII | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Low relative to I (pmol internalized peptide/mg pr | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1086 | 10323198 | LLKTTELLKTTELLKTTE | L | XIV | Designed Model peptide | Synthetic | Non-amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Unknown | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1087 | 10323198 | RQIKIWFQNRRMKWKK | L | XV | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Unknown | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1088 | 10998065 | klalklalkalkaalkla | D | D form of KLA | Designed Model peptide | Synthetic | Amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Unknown | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1089 | 10998065 | KALKLKLALALLAKLKLA | L | Derivative of KLA1 | Designed Model peptide | Synthetic | Non-amphipathic | Cytoplasm and nucleus | Labelled with fluorescein | Amidation | Unknown | Non-endocytic pathway | Aortic endothelial cells | Unknown |
|
| 1095 | 10784032 | RQIKIWFQNRRMKWKK | L | pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1096 | 10784032 | RQIKIWFQNRRMKWK | L | pAntp (43-57) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (55% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1097 | 10784032 | RQIKIWFQNRRMKW | L | pAntp (43-56) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (50% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1098 | 10784032 | RQIKIWFQNRRMK | L | pAntp (43-55) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (30% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1099 | 10784032 | RQIKIWFQNRRM | L | pAntp (43-54) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (20% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1100 | 10784032 | RQIKIWFQNRR | L | pAntp (43-53) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (25% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1101 | 10784032 | RQIKIWFQNR | L | pAntp (43-52) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (15% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1102 | 10784032 | RQIKIWFQN | L | pAntp (43-51) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (20% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1103 | 10784032 | RQIKIWFQ | L | pAntp (43-50) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (15% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1104 | 10784032 | RQIKIW | L | pAntp (43-48) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (20% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | Unknown |
|
| 1105 | 10784032 | QIKIWFQNRRMKWKK | L | pAntp (44-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (85% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1106 | 10784032 | IKIWFQNRRMKWKK | L | pAntp (45-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (95% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1107 | 10784032 | KIWFQNRRMKWKK | L | pAntp (46-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (65% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1108 | 10784032 | IWFQNRRMKWKK | L | pAntp (47-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (50% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1109 | 10784032 | WFQNRRMKWKK | L | pAntp (48-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (55% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1110 | 10784032 | FQNRRMKWKK | L | pAntp (49-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (65% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1111 | 10784032 | QNRRMKWKK | L | pAntp (50-58) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (60% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1112 | 10784032 | NRRMKWKK | L | pAntp (51-58) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (60% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1113 | 10784032 | RRMKWKK | L | pAntp (52-58) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (50% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1114 | 10784032 | RMKWKK | L | pAntp (53-58) | Antennapedia homeodomain of drosophila | Protein derived | Unknown | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (25% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | Unknown |
|
| 1115 | 10784032 | AQIKIWFQNRRMKWKK | L | Ala43 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (90% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1116 | 10784032 | RAIKIWFQNRRMKWKK | L | Ala44 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (65% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1117 | 10784032 | RQAKIWFQNRRMKWKK | L | Ala45 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (80% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1118 | 10784032 | RQIAIWFQNRRMKWKK | L | Ala46 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (50% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1119 | 10784032 | RQIKAWFQNRRMKWKK | L | Ala47 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (55% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1120 | 10784032 | RQIKIAFQNRRMKWKK | L | Ala48 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (65% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1121 | 10784032 | RQIKIWAQNRRMKWKK | L | Ala49 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (90% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1122 | 10784032 | RQIKIWFANRRMKWKK | L | Ala50 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (90% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1123 | 10784032 | RQIKIWFQARRMKWKK | L | Ala51 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (60% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1124 | 10784032 | RQIKIWFQNARMKWKK | L | Ala52 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (45% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1125 | 10784032 | RQIKIWFQNRAMKWKK | L | Ala53 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (30% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1126 | 10784032 | RQIKIWFQNRRAKWKK | L | Ala54 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | High (90% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1127 | 10784032 | RQIKIWFQNRRMAWKK | L | Ala55 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (25% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1128 | 10784032 | RQIKIWFQNRRMKAKK | L | Ala56 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Medium (40% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1129 | 10784032 | RQIKIWFQNRRMKWAK | L | Ala57 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (20% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1130 | 10784032 | RQIKIWFQNRRMKWKA | L | Ala58 substitution mutant of pAntp (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Probably Amphipathic | Probably Cytosol and nucleus, nucleoi | Labeled with Biotinyl-bAla | Amidation | Low (20% relative to (pAntp) (43-58)) | Non-endocytic pathway | HaCat/ A549 cells | US 7153931 |
|
| 1131 | 10784032 | CRQIKIWFPNRRMKWKKC | L | Reduced linear penetratin | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Unknown | Labeled with Biotinyl-Ahx | Unknown | Unknown | Non-endocytic pathway | HaCat/ A549 cells | Unknown |
|
| 1132 | 10784032 | RQIKIWFPNRRMKWKK | L | Penetratin (pAntp) (43-58) | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Cytosol and nucleus, nucleoi | Labeled with fluorescein | Amidation | Unknown | Non-endocytic pathway | HaCat/ A549 cells | Unknown |
|
| 1136 | 12849987 | RRRRRRRW | L | R7W | Positively charged sequence | Synthetic | Cationic | Cytoplasm and nucleus | Labeled with fluorescein | Amidation | Unknown | Energy-independent non-endocytic pathway | PC-12 and V79 cells | Unknown |
|
| 1138 | 12849987 | GRKKRRQRRRPWQ | L | TatP59W | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus | Labeled with fluorescein | Amidation | Comparable to that of (pAntp) (43-58) | Non-endocytic pathway | V79 cells | Unknown |
|
| 1217 | 21359136 | VPMLK | L | Bip1 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | High (97% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1218 | 21359136 | VPTLK | L | Bip2 | Bax-binding domain of mouse Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Cytosole | Labelled with fluorescein | Free | Medium (61% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI, Jurkat, CHO A745, CHO K1, and HeLa | Unknown |
|
| 1219 | 21359136 | VPALR | L | Bip3 | Bax-binding domain of rat Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Medium (79% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1220 | 21359136 | VSALK | L | Bip4 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | High (90% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1221 | 21359136 | PMLKE | L | Bip5 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Medium (65% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1222 | 21359136 | VPALK | L | Bip6 | Bax-binding domain of cattle Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Medium (71% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1223 | 21359136 | VSLKK | L | Bip7 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1224 | 21359136 | VSGKK | L | Bip8 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1225 | 21359136 | KLPVM | L | Bip9 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | High | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI and HeLa | Unknown |
|
| 1226 | 21359136 | IPMIK | L | Bip10 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Medium (47% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1227 | 21359136 | KLGVM | L | Bip11 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1228 | 21359136 | KLPVT | L | Bip12 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1229 | 21359136 | VPMIK | L | Bip13 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1230 | 21359136 | IPALK | L | Bip14 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1231 | 21359136 | IPMLK | L | Bip15 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1232 | 21359136 | VPTLQ | L | Bip16 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Medium (70% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1233 | 21359136 | QLPVM | L | Bip17 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1234 | 21359136 | ELPVM | L | Bip18 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1235 | 21359136 | VPTLE | L | Bip19 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | High (80% of KLPVM) | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1236 | 21359136 | vptlk | D | Bip20 | Bax-binding domain of human Ku70 | Protein derived (Cell penetrating pentapeptides) | Unknown | Unknown | Labelled with fluorescein | Free | Unknown | Mechanisms other than endocytic and pinocytic process (Non-endocytic pathway) | DAMI cells | Unknown |
|
| 1396 | 11084031 | RRRRNRTRRNRRRVRGC | L | FHV coat (35-49) | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Comparable with that of the Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1397 | 11084031 | TRRQRTRRARRNRGC | L | HTLV -II Rex(4 –16) | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Comparable with that of the Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1398 | 11084031 | KMTRAQRRAAARRNRWTARGC | L | BMV GAG | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Comparable with that of the Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1399 | 11084031 | KLTRAQRRAAARKNKRNTRGC | L | CCMV GAG | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Moderate relative to Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1400 | 11084031 | NAKTRRHERRRKLAIERGC | L | P22 N | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Moderate relative to Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1401 | 11084031 | MDAQTRRRERRAEKQAQWKAANGC | L | LAMBDA N (1-22) | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Less relative to Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1402 | 11084031 | TAKTRYKARRAELIAERRGC | L | PHI 21 N (12-29) | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Less relative to Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1403 | 11084031 | SQMTRQARRLYBGC | L | Human U2AF (142-153) | RNA Binding Peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | No uptake observed | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1404 | 11084031 | KRRIRRERNKMAAAKSRNRRRELTDTGC | L | Human c Fos (139-164) | DNA binding peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Unknown | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1405 | 11084031 | RIKAERKRMRNRIAASKSRKRKLERIARGC | L | Human c Jun (252-279) | DNA binding peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Unknown | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1406 | 11084031 | KRARNTEAARRSRARKLQRMKQGC | L | Yeast GCN 4 (231-252) | DNA binding peptides | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-terminal Gly Cys amide labelled with fluorescein | Less relative to Tat-(48–60) peptide | Non-endocytic pathway | RAW 264.7 | Unknown |
|
| 1417 | 11731788 | KETWWETWWTEWSQPKKKRKV | L | Pep-1 | Trp rich cluster + SV40 NLS | Chimeric | Amphipathic | Nucleus | Acetylation | Cysteamide at C-Terminus (FITC labelling) | Unknown | Non-endocytic pathway | HS-68 and NIH-3T3 | Unknown |
|
| 1418 | 20188697 | KETWFETWFTEWSQPKKKRKV | L | Pep-2 | Trp rich cluster + SV40 NLS | Chimeric | Amphipathic | Probably nucleus | Acetylation | Cysteamide at C-Terminus (FITC labelling) | Unknown | Probably non-endocytic pathway | HeLa | Unknown |
|
| 1419 | 20188697 | KWFETWFTEWPKKRK | L | Pep-3 | Trp rich cluster + SV40 NLS | Chimeric | Amphipathic | Probably nucleus | Acetylation | Cysteamide at C-Terminus (FITC labelling) | Unknown | Probably non-endocytic pathway | HeLa | Unknown |
|
| 1422 | 9008163 | DAATATRGRSAASRPTQRPRAPARSASRPRRPVE | L | VP22 | HSV-1 envelop protein 22 | Protein derived | Unknown | Nucleus | Unknown | Unknown | Unknown | Non-endocytic pathway | Cos-1 cells | Unknown |
|
| 1423 | 12771197 | GALFLGFLGAAGSTMGAWSQPKKKRKV | L | MPG | HIV GP41 + SV 40 NLS | Chimeric | Amphipathic | Nucleus | Acetylation | Cysteamide at C-Terminus | Unknown | Non-endocytic pathway | HS-68, Cos-7 and HeLa | Unknown |
|
| 1424 | 12771197 | GALFLGFLGAAGSTMGAWSQPKSKRKV | L | MPG Mutant | HIV GP41 + SV 40 NLS | Chimeric | Amphipathic | Nucleus | Acetylation | Cysteamide at C-Terminus | Lower than wilde type MPG | Non-endocytic pathway | HS-68, Cos-7 and HeLa | Unknown |
|
| 1427 | 10822301 | PLSSIFSRIGDP | L | PreS2 (41-52) | PreS2 domain of hepatitis-B virus surface antigens | Protein derived | Amphipathic | Cytosol | Conjugated with EGFP | Free | Unknown | Non-endocytic pathway | HepG2, HeLa and 293 cells | Unknown |
|
| 1428 | 10822301 | PSSSSSSRIGDP | L | PreS2 3S Mutant | PreS2 domain of hepatitis-B virus surface antigens | Protein derived | Non-amphipathic | Cytosol | Conjugated with EGFP | Free | Unknown | Probably non-endocytic pathway | HepG2, HeLa and 293 cells | Unknown |
|
| 1431 | 12119035 | ALWMTLLKKVLKAAAKAALNAVLVGANA | L | Dermaseptin S4 | Dermaseptins family | Protein derived | Antimicrobial | Cytoplasm | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
| 1432 | 12119035 | ALWKTLLKKVLKA | L | S4(13) | Dermaseptin S4 | Protein derived | Antimicrobial | Cytoplasm | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
| 1433 | 12119035 | ALWKTLLKKVLKAPKKKRKV | L | S4(13)-PV | Dermaseptin S4 peptide + SV40 NLS | Chimeric | Karyophilic | Cytoplasm and nucleus | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
| 1434 | 12119035 | PKKKRKVALWKTLLKKVLKA | L | PV-S4(13) | SV40 NLS + dermaseptin S4 peptide | Chimeric | Karyophilic | Cytoplasm and nucleus | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
| 1435 | 12119035 | VKRKKKPALWKTLLKKVLKA | L | PV reverse-S4(13) | Dermaseptin S4 peptide + SV40 NLS reverse | Chimeric | Unknown | Cytoplasm | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
| 1436 | 12119035 | RQARRNRRRALWKTLLKKVLKA | L | RR-S4(13) | Rev ARM + Dermaseptin S4 peptide | Chimeric | Karyophilic | Cytoplasm and nucleus | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
| 1437 | 12119035 | RQARRNRRRC | L | Rev ARM | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
| 1438 | 12119035 | GRKKRRQRRRPPQC | L | Tat ARM | HIV-1 | Protein derived | Cationic | Cytoplasm and nucleus | Labelled rhodamine | Amidation | Unknown | Non-endocytic pathway | HeLa | US 20040132970 |
|
| 1440 | 21029412 | EEE | L | Glu | Unknown | Synthetic | Unknown | Cytoplasm | Free | Labelled with FITC | Low | Receptor-independent non-endocytic pathway | DU-145 and LNCaP | US 20100137187 |
|
| 1441 | 21029412 | EEEAA | L | Glu-Ala | Unknown | Synthetic | Unknown | Cytoplasm | Free | Labelled with FITC | Low | Receptor-independent non-endocytic pathway | DU-145 and LNCaP | US 20100137187 |
|
| 1442 | 21029412 | EEEAAKKK | L | Glu-Lys | Unknown | Synthetic | Unknown | Cytoplasm | Free | Labelled with FITC | Lower than Glu-Oct-6 but higher than Oct-6 | Receptor-independent non-endocytic pathway | DU-145 and LNCaP | US 20100137187 |
|
| 1490 | 11716681 | RQIKIWFQNRRMKWKK | L | Penetratin {pAntp-(43–58)} | Antennapedia homeodomain of drosophila | Protein derived | Amphipathic | Cytoplasm and nucleus | Biotinylation | Amidation | Unknown | Non-endocytic pathway | Human bowes melanoma cells | Unknown |
|
| 1491 | 11716681 | RVIRVWFQNKRCKDKK | L | pISL | Homeodomain of the rat transcription factor Islet- | Protein derived | Amphipathic | Cytoplasm and nucleus | Biotinylation | Amidation | Comparable to penetratin | Non-endocytic pathway | Human bowes melanoma cells | Unknown |
|
| 1500 | 11084031 | GRRRRRRRRRPPQ | L | R9-TAT | HIV 1 Tat derivative | Protein derived | Cationic | Cytoplasm and nucleus | Free | C-Terminal cysteine labelled with fluorescein | High comparable to Tat(48-60) | Probably non-endocytic pathway | RAW 264.7 cells | Unknown |
|
| 1542 | 9287160 | MGLGLHLLVLAAALQGAWSQPKKKRKV | L | Peptide 1 | Designed (Signal sequence + NLS) | Chimeric | Amphipathic | Nucleus | Acetylation | Cysteamide | Unknown | Non-endocytic pathway (direct translocation) | HS-68 Cells | Unknown |
|
| 1543 | 9287160 | MGLGLHLLVLAAALQGAKKKRKV | L | Peptide 2 | Designed (Signal sequence + NLS) | Chimeric | Amphipathic | Nucleus | Acetylation | Cysteamide | Unknown | Non-endocytic pathway (direct translocation) | HS-68 Cells | Unknown |
|
| 1553 | Unknown | PPKKSAQCLRYKKPE | L | Secretory leukoprotease inhibitor derived PTD | Secretory leukoprotease inhibitor | Protein derived | Unknown | Nucleus | FITC Labeling | Unknown | Unknown | Non-endocytic pathway | P5 DRG neurons | US20110107443 |
|
| 1554 | Unknown | DPVDTPNPTRRKPGK | L | Secretory leukoprotease inhibitor derived PTD | Secretory leukoprotease inhibitor | Protein derived | Unknown | Nucleus | FITC Labeling | Unknown | Unknown | Non-endocytic pathway | P5 DRG neurons | US20110107443 |
|
| 1555 | 15346201 | KRVSRNKSEKKRR | L | hClock-(35-47) | Human Clock protein DNA-binding peptide | Protein derived | Cationic | Cytoplasm and nucleus, but mainly in the nucleus with a nucleolar accumula | FITC Labeling | Unknown | Similar to Tat (48-60) | Non-endocytic pathway | ECV-304 and the primary neuroglial cells | Unknown |
|
| 1556 | 15781181 | GRRHHCRSKAKRSRHH | L | hPER1- PTD (830-846) NLS | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Non-endocytic pathway | CHO | US 7754678 |
|
| 1557 | 15781181 | SARHHCRSKAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
| 1558 | 15781181 | SRAHHCRSKAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
| 1559 | 15781181 | SRRAHCRSKAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
| 1560 | 15781181 | SRRHACRSKAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
| 1561 | 15781181 | SRRHHARSKAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
| 1562 | 15781181 | SRRHHCRAKAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
| 1563 | 15781181 | SRRHHCRSAAKRSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
| 1564 | 15781181 | SRRHHCRSKAARSRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
| 1565 | 15781181 | SRRHHCRSKAKASRHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
| 1566 | 15781181 | SRRHHCRSKAKRARHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
| 1567 | 15781181 | SRRHHCRSKAKRSAHH | L | hPER1-PTD alanine subsitution mutant | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |
|
| 1568 | 15781181 | RRHHCRSKAKRSR | L | hPER1-PTD | Human period 1 circadian protein | Protein derived | Unknown | Cytoplasm and nucleus | Biotin labeling | Free | Unknown | Probably non-endocytic pathway | CHO | US 7754678 |